Google sign-in. No card required.
Revolution Medicines is a global, commercial-state oncology company dedicated to discovering, developing and delivering innovative medicines for patients with RAS-addicted cancers. Leveraging its differentiated RAS(ON) tri-complex inhibitor platform, the company is advancing a broad, integrated portfolio of oral RAS(ON) inhibitors designed to directly target the active, cancer-driving state of RAS. Founded on rigorous scientific inquiry and a willingness to challenge long-held assumptions, Revolution Medicines is committed to changing the trajectory of disease for patients with RAS-addicted cancers worldwide.
Our people are united by a shared way of working: follow the science, challenge assumptions, act with urgency and hold ourselves to a high standard of rigor—all in service of patients.
The Opportunity:
The Director, Commercialization Partnerships and Operations serves as the primary operational and partnership role at RevMed headquarters supporting the Senior Director, Commercialization Partnerships and Operations This role is responsible for driving operational and partnership excellence, governance structure, financial tracking, and cross-functional alignment across select regional commercialization partners and territory-specific distributors. This role will also partner with regional commercial heads to support relationship management and commercial readiness across the same distribution partner(s).
By serving as the central HQ liaison, this role ensures seamless coordination between RevMed’s internal functional teams (Supply Chain, Regulatory, Quality, Medical Affairs, Finance) and external partners including regional commercial and distribution partners to achieve commercial readiness, regulatory/MAA approval, compliant named-patient access programs, and reliable product supply for a select region.
Core Responsibilities & Scope:
Key Performance Indicators (KPIs) & Governance Framework
-
Consistent KPI Architecture : Establish, standardize, and monitor a unified commercial and operational KPI framework across select region/partner.
-
Commercial & Non-Commercial KPIs: Forecast/order accuracy, market access, medical information metrics, performance to volume targets, order-to-cash cycle times, stockout frequency, inventory buffer levels, and lead-time adherence.
-
Regulatory & Quality KPIs : Variances/amendment submission timelines, adherence to quality and PV agreements.
-
Governance & Decision-Making: Operationalize joint governance bodies (e.g., Joint Steering Committees [JSC], Joint Commercial Committees [JCC], and Joint Operations Committees [JOC]) and joint pricing decisions.
-
Define escalation pathways, charter guidelines, voting rights, and decision-making matrices (RevMed vs. Partner/Distributor) across commercial, pricing, regulatory, and supply chain domains.
Financial Reporting & Revenue Reconciliation
-
Quarterly Financial Tracking: Partner with RevMed HQ Finance and Partner Commercial Operations to track, report, and analyze quarterly commercial revenue, transfer pricing, and royalty/profit-share milestones. Reconcile financial tracking on quarterly basis as necessary.
-
KPI-Based Financial Reconciliation: Lead the quarterly financial reconciliation process across partners based on contracted KPIs, volume tiers, milestone achievements, and operational claw backs or bonuses.
-
Commercial Dashboard Management: Maintain real-time executive dashboards reporting financial performance, sales volume, inventory valuation, and partner margin compliance.
Required Skills, Experience and Education:
-
Education: B.S./B.A. in Business, Life Sciences, Supply Chain, or Finance (MBA or advanced degree preferred).
-
Experience: 8–12+ years of experience in the biopharmaceutical industry, with direct experience in Alliance Management, Commercial Operations, Strategic Account Operations, or Global Program Management.
-
Cross-Functional Expertise: Proven track